NCT06491342View on ClinicalTrials.gov

Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver Disease

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 25, 2024

Primary Completion Date

April 22, 2025

Study Completion Date

May 28, 2025

Conditions
Fatty Liver, Nonalcoholic
Interventions
DIETARY_SUPPLEMENT

Probiotic

Probiotic-Lactobacillus Zeae and Lactobacillus reuteri

DIETARY_SUPPLEMENT

Placebo

placebo

Trial Locations (2)

10400

Division of gastroenterology and hepatology, Ratchathewi

50200

Chiangmai university, Chiang Mai

All Listed Sponsors
collaborator

Chiang Mai University

OTHER

collaborator

Thailand Institute of scientific and technological research

UNKNOWN

lead

Phramongkutklao College of Medicine and Hospital

OTHER

NCT06491342 - Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter